BackEvents

Akros SCHK HK-U.S. Quality Factor Index

TickerASHUQLT
CurrencyHKD

Sentiment Summary

Positive
12
Neutral
22
Negative
2

Recent Events

Other

Ex-dividend date for the proposed 2025 final dividend of HK$0.50 per share, a 52% increase from the previous year. The dividend was announced on 2026-03-18, scheduled.

6/3/2026, 12:00:00 AM
Lyft Inc (LYFT)
Other

Lyft's 2026 annual stockholders meeting is scheduled for June 3, 2026, to vote on the election of directors, ratification of the auditor, and executive compensation. A 1% price movement is estimated as these are routine matters, scheduled.

Other

Ex-dividend date (2026-05-15) for the final dividend of HKD 1.08 per share for the year ended Dec 31, 2025. The dividend distribution is expected to result in a >1% price impact scheduled.

5/15/2026, 12:00:00 AM
Medpace Holdings Inc (MEDP)
Other

The Annual Meeting of Stockholders is scheduled to be held virtually on May 15, 2026; a Low impact is estimated as annual meetings generally result in minimal immediate price volatility, scheduled.

Other

Ex-dividend date (2026-05-12) for the RMB 0.75 per share final dividend for fiscal year 2025; low importance due to expected minor price adjustment of approximately 1%, scheduled.

5/6/2026, 12:00:00 AM
AppLovin Corporation (APP)
Earnings Release

AppLovin is scheduled to report its financial results for the first quarter of 2026 after the U.S. market close on May 6, 2026, scheduled.

5/6/2026, 12:00:00 AM
Lyft Inc (LYFT)
Earnings Release

Lyft's Q1 2026 earnings release is expected on or around May 6, 2026, with gross bookings guidance between $4.86 billion and $5 billion. A 5% price volatility is estimated based on historical earnings reactions, expected.

4/30/2026, 12:00:00 AM
Apple Inc (AAPL)
Earnings Release

Apple's fiscal second quarter 2026 earnings results and conference call on April 30, 2026, are scheduled. Analysts will monitor iPhone 17 sales and margins. Medium importance is estimated due to typical earnings-related price impact of 5% or more, and the event is scheduled.

4/30/2026, 12:00:00 AM
Illinois Tool Works Inc. (ITW)
Earnings Release

Illinois Tool Works is scheduled to release its Q1 2026 financial results on April 30, 2026, before the market opens. Estimated impact is Medium as earnings reports typically drive significant price movement for industrial stocks scheduled.

4/29/2026, 12:00:00 AM
Kinross Gold Corp (KGC)
Earnings Release

Kinross Gold is scheduled to release its financial and operating results for the first quarter of 2026 after the market closes on April 29, 2026, with a conference call the following morning; high importance is estimated due to potential for >10% price impact, expected.

4/29/2026, 12:00:00 AM
KLA Corp (KLAC)
Earnings Release

KLA's fiscal third-quarter 2026 earnings release is scheduled for April 29, 2026. A price impact of at least 5% is estimated based on historical earnings volatility, and the event is scheduled.

Earnings Release

First quarter 2026 unaudited financial results to be reviewed and approved by the board of directors, scheduled.

Earnings Release

Board meeting to approve Q1 2026 financial results scheduled for April 28, 2026, with results expected on April 29, 2026; high impact expected due to anticipated earnings volatility.

4/27/2026, 12:00:00 AM
WuXi AppTec Co Ltd (2359)
Earnings Release

Estimated low impact (<5%) as the date announcement is routine; first quarter 2026 earnings results are scheduled.

Earnings Release

Board meeting to be held to approve the unaudited first quarter results for the three months ended March 31, 2026, scheduled.

Earnings Release

A board meeting is scheduled to be held on April 24, 2026, to approve the unaudited first quarter results for the three months ending March 31, 2026. This routine quarterly update is estimated to have a moderate market impact of approximately 5%, scheduled.

Implementation of 2025 annual cash dividend of CNY 69.57 per 10 shares. The ex-dividend date is scheduled for April 22, 2026.

4/22/2026, 12:00:00 AM
Lam Research Corp (LRCX)
Earnings Release

Lam Research is scheduled to release its fiscal third-quarter 2026 financial results after the market closes on April 22, 2026. High importance is estimated due to potential price impact exceeding 10% typical of semiconductor earnings. Analysts forecast revenue of $5.70 billion and EPS of $1.35. This event is scheduled.

Earnings Release

Board meeting to approve and publish the first quarter 2026 financial results; market impact is estimated at ~5% as quarterly results often drive significant price volatility, expected.

4/22/2026, 12:00:00 AM
Medpace Holdings Inc (MEDP)
Earnings Release

First quarter 2026 financial results to be reported after market close on April 22, 2026, with analysts forecasting earnings of approximately $3.74 per share; a Medium impact is estimated as earnings reports typically drive significant price movement, forecasted.

Earnings Release

Board of Directors meeting to approve the unaudited first quarter results for the three months ended March 31, 2026 on 2026-04-21 is scheduled.

Earnings Release

Released Q1 2026 earnings, reporting revenue of CNY 129.13 billion (+52.45% YoY) and net profit of CNY 20.74 billion (+48.52% YoY).

4/15/2026, 12:00:00 AM
JD Logistics Inc (2618)
Other

Multiple analysts (including Bank of America, Morgan Stanley, Nomura) released positive forecasts for Q1 2026 on 2026-04-15, predicting revenue growth of ~25% and non-IFRS net profit growth of ~37% estimated.

Announced the investment and establishment of a wholly-owned subsidiary, Times Resources Group, with a registered capital of CNY 30 billion to manage upstream new energy mineral resources.

4/15/2026, 12:00:00 AM
Kinross Gold Corp (KGC)
Other

On April 15, 2026, the Impact Assessment Agency of Canada initiated a public consultation period for the Great Bear gold project, a key step in the federal environmental review process.

Announced that its subsidiary received approval from China's National Medical Products Administration (NMPA) for the clinical trial of HRS-7156 tablets, a self-developed Class 1 new drug for heart failure. Market impact is estimated at ~1% as clinical trial approvals for early-stage drugs typically have limited immediate price impact.

Signed a strategic partnership with SAIC-GM-Wuling to become the core battery partner for over 15 new models and to jointly develop fast-charging technology.

Other

Announced Q1 2026 operational data on April 14, 2026, reporting a 4.82% YoY decrease in on-grid power generation and a 5.63% YoY decrease in the average on-grid tariff.

Other

Daiwa analysts downgraded the stock rating from 'Outperform' to 'Underperform' on April 14, 2026, citing concerns that earnings may have peaked and tariff cuts could weigh on 2026 earnings, forecasted.

4/14/2026, 12:00:00 AM
NVIDIA Corporation (NVDA)
Other

NVIDIA announced 'Ising' on April 14, 2026, the world's first family of open-source AI models designed to accelerate research and development in quantum computing by improving processor calibration and error correction.

4/14/2026, 12:00:00 AM
NVIDIA Corporation (NVDA)
Other

On April 14, 2026, NVIDIA officially denied a media report that it was in discussions to acquire a major PC manufacturer. The rumor had caused a brief stock price increase for PC makers like HP and Dell.

Earnings Release

Q1 2026 operational update (2026-04-13): ANTA brand retail sales recorded high-single-digit YoY growth, FILA brand recorded 10-20% low-band YoY growth, and all other brands recorded 40-45% YoY growth. Strong growth across segments is expected to result in a >5% price impact scheduled.

Other

Announced Q1 2026 sales volume for the listed company (Geely Automobile Holdings Ltd.) of 709,358 units, up 1% year-over-year. NEV sales grew 9% and exports grew 126%.

Other

Raised the full-year 2026 export sales target to 750,000 vehicles from the previous target of 640,000, following strong first-quarter performance.

Signed a strategic cooperation agreement with Jianlong Group to promote the electrification of the steel industry, planning to deploy over 3,000 electric heavy trucks and 100 battery swap stations.

Announced that its subsidiary received approval from China's NMPA for the clinical trial of HRS-5765 tablets, a self-developed Class 1 new drug for heart failure. Market impact is estimated at ~1% as clinical trial approvals for early-stage drugs typically have limited immediate price impact.

By Event Type